US Contraceptive Devices Market Report 2022 to 2030

US Contraceptive Devices Market Analysis

$ 3999

US's contraceptive devices market is projected to grow from $5.4 Bn in 2022 to $8.6 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US contraceptive devices market is a growing and dynamic market that includes a range of products designed to prevent pregnancy. Bayer is a German multinational pharmaceutical company that manufactures a range of contraceptive products, including oral contraceptives and IUDs.

ID: IN10USMD005 CATEGORY: Medical Devices GEOGRAPHY: US AUTHOR: Shivam Zalke

Buy Now

US Contraceptive Devices Market Executive Summary

According to forecasts, the US market for contraceptive devices would increase from $5.4 billion in 2022 to $8.6 billion in 2030, exhibiting a 6% CAGR throughout that time.

The market for contraceptive devices in the US is expanding and dynamic, offering a variety of contraceptive solutions. Male and female users of contraceptive methods may employ a variety of hormonal, barrier, and intrauterine contraceptive methods, among others (IUDs).

In general, the US market for contraceptive devices is expanding and dynamic, and it is predicted that this growth will continue in the years to come. The market is characterized by rising STI prevalence, government efforts and programs, growing knowledge of and adoption of contraceptive methods, and technical improvements.

US contraceptive devices market analysis

Market Dynamics

Market Growth Drivers

Growing knowledge and acceptability of contraceptive methods: One of the main factors driving the market in the US is the rising awareness and acceptance of contraceptive methods among both men and women. Younger generations in particular are becoming more aware of the significance of birth control and family planning.
Government projects and initiatives: The US government has started a number of projects and programs to encourage the use of contraceptives, especially among low-income groups. These initiatives have improved access to contraceptive methods and are boosting consumer demand.
Technological progress The creation of novel and cutting-edge contraceptive methods is propelling industry expansion. These gadgets are growing increasingly popular among women as they becoming more useful, practical, and simple to use.
The frequency of sexually transmitted infections (STIs) is rising: The demand for barrier contraceptive methods like condoms, which may aid in STI prevention, is growing as STI incidence rises in the US.

Competitive Landscape

Key Players

Bayer AG
Merck & Co., Inc.
CooperSurgical, Inc.
Church & Dwight Co., Inc.
Reckitt Benckiser Group plc
The Female Health Company
Allergan plc
HLL Lifecare Limited

These are some of the leading players in the US contraceptive devices market, but many other companies also play a significant role in the market.

Healthcare Policies and Regulatory Landscape

The safety and efficacy of medical devices, including contraceptive devices, are governed by the US Food and Drug Administration (FDA). Medical devices fall into one of three categories according to the FDA:

Class I (low risk)
Class II (moderate risk), and
Class III (high risk)

Usually, contraceptive methods fall within the Class II or Class III categories.

Before their goods may be sold in the US, medical device makers must file premarket notice (510(k)) or premarket approval (PMA) applications to the FDA. For Class II devices, the 510(k) route is utilized, but for Class III devices, the PMA pathway is used. Information about the device's efficacy and safety is included in these applications.

In addition to FDA regulation, the Affordable Care Act (ACA) mandates that the majority of health insurance plans cover the complete array of contraceptive methods that have been authorized by the FDA without the patient having to pay a copayment. This covers emergency contraception, hormonal implants, and Intrauterine Devices (IUDs).

Some authorities have attempted to limit access to certain contraceptive methods, however. For instance, based on ideological opposition to its usage, certain nations have tried to impede access to IUDs and other Long-acting Reversible Contraceptives (LARCs).

Generally, the US regulatory environment for contraceptive devices is complicated and influenced by politics. Contraceptive devices, however, go through extensive safety and effectiveness testing before they are licensed for use in the US thanks to the FDA's monitoring of medical devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.